Announcements Trials
Browse Landscape

Status

Completed 3Withdrawn 1Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 6Other hematologic neoplasm 3Gynecologic 2Gastrointestinal 2Sarcoma 1Head & Neck 1Dermatologic 1

Conditions

Melanoma, Cutaneous Malignant 1Melanoma 1

Interventions

Nivolumab 25pembrolizumab 21Ipilimumab 15Temozolomide 13toripalimab 12Biopsy 10Imiquimod 8Cyclophosphamide 8Dacarbazine 7Blood Specimen Collection 7camrelizumab 6Chemotherapy, Adjuvant 6trametinib 5dabrafenib 5atezolizumab 5aldesleukin 5Gene Expression Profiling 5Cisplatin 5Aminolevulinic Acid 5fludarabine phosphate 4fludarabine 4durvalumab 4binimetinib 4apatinib 4Tomography, Optical Coherence 4Sorafenib 4Photochemotherapy 4Injections 4Bevacizumab 4tislelizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Microarray Analysis × Dermatologic × Clear all
NCT00450593 2013-08-12

Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma

National Cancer Institute (NCI)

Unknown
5,000 enrolled
Dermatologic

Melanoma, Cutaneous Malignant, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡